Skip to main content

Peer Review reports

From: Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy

Original Submission
26 Nov 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
29 Dec 2020 Reviewed Reviewer Report
6 Jan 2021 Reviewed Reviewer Report
28 Jan 2021 Author responded Author comments - Meng-Ru Shen
Resubmission - Version 5
28 Jan 2021 Submitted Manuscript version 5
2 Feb 2021 Author responded Author comments - Meng-Ru Shen
Resubmission - Version 6
2 Feb 2021 Submitted Manuscript version 6
9 Feb 2021 Reviewed Reviewer Report
15 Feb 2021 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
17 Feb 2021 Editorially accepted
2 Mar 2021 Article published 10.1186/s12885-021-07926-1

You can find further information about peer review here.

Back to article page